M&T Bank
IOVA icon

M&T Bank’s Iovance Biotherapeutics IOVA Stock Holding History

M&T Bank’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,464
Closed -$31.3K – 1758
2025
Q4 		$31.3K Buy
+11,464
New +$26.5K ﹤0.01% 1669
2021
Q1 		– Sell
-13,786
Closed -$640K – 1635
2020
Q4 		$640K Buy
13,786
+840
+6% +$33.4K ﹤0.01% 935
2020
Q3 		$427K Buy
12,946
+2,697
+26% +$82.7K ﹤0.01% 1063
2020
Q2 		$281K Buy
10,249
+420
+4% +$13.8K ﹤0.01% 1223
2020
Q1 		$294K Sell
9,829
-1,171
-11% -$31K ﹤0.01% 1139
2019
Q4 		$304K Hold
11,000
– – ﹤0.01% 1079
2019
Q3 		$200K Hold
11,000
– – ﹤0.01% 1433
2019
Q2 		$270K Buy
+11,000
New +$166K ﹤0.01% 1281

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

M&T Bank's IOVA Position: Q1 2026 in Review

M&T Bank sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 11,464 shares — an estimated $31.3K sold.

M&T Bank first reported a position in IOVA in Q2 2019 and held it in 8 quarters. The position peaked at $640K in Q4 2020. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • M&T Bank reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • M&T Bank sold 11,464 Iovance Biotherapeutics shares in Q1 2026, an estimated $31.3K.
  • M&T Bank first reported a position in Iovance Biotherapeutics in Q2 2019 and held it in 8 quarters.
  • M&T Bank's Iovance Biotherapeutics position peaked at $640K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.